SiriusPoint Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SiriusPoint Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.21B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.60B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.74B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.11B | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | $398.00M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $732.60M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $561.50M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $488.60M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $386.81M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $263.67M | Feb 23, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $459.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $199.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $354.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($386.80M) | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | ($136.30M) | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | ($44.00M) | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $68.50M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $169.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $134.40M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $68.74M | Feb 23, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $74.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $581.30M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $293.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $73.30M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $141.10M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $13.39M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | ($78.54M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $4.77M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $12.52B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $12.87B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $11.04B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $10.62B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $3.54B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.44B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.09B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $4.67B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $3.90B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.10B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $10.59B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $10.34B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $8.95B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.12B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.97B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.03B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.88B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.90B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.45B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.47B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.94B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $2.51B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.07B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.50B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.56B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.41B | Feb 23, 2021 |
| FY2020 | Dec 31, 2018 | $1.20B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $1.66B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.41B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $784.90M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $601.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $262.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $665.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $620.40M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $476.95M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $276.33M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $594.02M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $316.22M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $731.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $682.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $969.20M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $705.30M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $999.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $526.00M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $639.42M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $104.18M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $8.20M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $9.95M | Mar 1, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $688.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $639.10M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $786.20M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $778.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $816.70M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $114.30M | Mar 1, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | 1 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | 1 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 116.99M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 116.43M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 168.12M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 162.18M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 161.93M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 95.58M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | 94.23M | Mar 1, 2022 |
| FY2021 | Dec 31, 2018 | 93.64M | Mar 1, 2022 |
| FY2019 | Dec 31, 2017 | 103.28M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | 105.86M | Feb 28, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $0 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Feb 24, 2023 |